← Back to Search
Some data provided by SemanticScholar
Synergy Between Enzyme Inhibitors Of Fatty Acid Amide Hydrolase And Cyclooxygenase In Visceral Nociception
P. S. Naidu, L. Booker, B. Cravatt, A. Lichtman
Published 2009 · Chemistry, Medicine
Twitter
Facebook
LinkedIn
Email The present study investigated whether inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for anandamide catabolism, produces antinociception in the acetic acid-induced abdominal stretching model of visceral nociception. Genetic deletion or pharmacological inhibition of FAAH reduced acetic acid-induced abdominal stretching. Transgenic mice that express FAAH exclusively in the nervous system displayed the antinociceptive phenotype, indicating the involvement of peripheral fatty acid amides. The cannabinoid receptor 1 (CB1) receptor antagonist, rimonabant, but not the cannabinoid receptor 2 (CB2) receptor antagonist, SR144528, blocked the antinociceptive phenotype of FAAH(-/-) mice and the analgesic effects of URB597 (3′-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate) or OL-135 (1-oxo-1[5-(2-pyridyl)-2-yl]-7-phenyl heptane), respective irreversible and reversible FAAH inhibitors, administered to C57BL/6 mice. The opioid receptor antagonist, naltrexone, did not block the analgesic effects of either FAAH inhibitor. URB597, ED50 [95% confidence interval (CI) = 2.1 (1.5-2.9) mg/kg], and the nonselective cyclooxygenase inhibitor, diclofenac sodium [ED50 (95% CI) = 9.8 (8.2-11.7) mg/kg], dose-dependently inhibited acetic acid-induced abdominal stretching. Combinations of URB597 and diclofenac yielded synergistic analgesic interactions according to isobolographic analysis. It is important that FAAH(-/-) mice and URB597-treated mice displayed significant reductions in the severity of gastric irritation caused by diclofenac. URB597 lost its gastroprotective effects in CB1(-/-) mice, whereas it maintained its efficacy in CB2(-/-) mice, indicating a CB1 mechanism of action. Taken together, the results of the present study suggest that FAAH represents a promising target for the treatment of visceral pain, and a combination of FAAH inhibitors and NSAIDs may have great utility to treat visceral pain, with reduced gastric toxicity.
This paper references
10.1124/jpet.108.146712
Identification and Quantification of 2′,3′-cAMP Release by the Kidney
J. Ren (2009)
10.1124/jpet.107.119941
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice
R. Russo (2007)
10.1096/fj.03-0645rev
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
T. Warner (2004)
Institute of Laboratory Animal Resources.
T. Wolfle (1995)
Aminoalkylin - dole analogs : cannabimimetic activity of a class of compounds structurally distinct from 9tetrahydrocannabinol
DR Compton (1992)
10.1038/sj.bjp.0704466
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
S. Conti (2002)
10.1023/A:1021077810548
Gastrointestinal Tolerability of Metamizol, Acetaminophen, and Diclofenac in Subchronic Treatment in Rats
S. Sanchez (2004)
10.1038/nn1916
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
N. Agarwal (2007)
10.1124/jpet.108.146381
Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine
K. Hosoya (2009)
10.1201/9781420036107
Drug Synergism and Dose-Effect Data Analysis
R. Tallarida (2000)
Supplemental material is available online at http://jpet.aspetjournals.org. About the cover: cypA and pin1 undergo subcellular redistribution after microtubule disruption in a variety of tumor cells
10.1038/sj.bjp.0706699
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
L. Chang (2006)
10.1155/1996/850710
NSAID gastroenteropathy: past, present and future.
J. Wallace (1996)
10.1007/3-540-26573-2_17
Cannabinoid mechanisms of pain suppression.
J. M. Walker (2005)
3Ј-Dideoxy-3Ј-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3 Gerard Minuesa
Doxorubicinolone Formation
10.1124/jpet.108.145862
Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis
S. M. Farooq (2009)
10.1073/pnas.161191698
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
B. Cravatt (2001)
10.1016/0014-2999(96)00015-5
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.
S. Mazzari (1996)
10.1038/35068566
Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity
T. Samad (2001)
10.1016/J.CHEMBIOL.2007.11.006
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
J. Blankman (2007)
Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
D. Compton (1992)
10.1016/S0960-894X(01)00211-6
α-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and α-substitution
D. Boger (2001)
10.1046/j.1365-2710.2001.00355.x
Pharmacology of oral combination analgesics: rational therapy for pain
R. Raffa (2001)
Giacomini 297 Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [ 13 C]Pantoprazole Breath Test Zeruesenay Desta
Sook Wah Yee
10.1124/JPET.302.1.73
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
A. Lichtman (2002)
10.1016/J.EJPHAR.2007.02.051
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
S. Holt (2007)
10.1038/nm803
Modulation of anxiety through blockade of anandamide hydrolysis
S. Kathuria (2003)
A (1996) N-(2hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
S Mazzari (1996)
10.1124/jpet.108.143453
Substrate Selectivity of 5-Hydroxyeicosanoid Dehydrogenase and Its Inhibition by 5-Hydroxy-Δ6-Long-Chain Fatty Acids
P. Patel (2009)
10.1016/S0024-3205(02)01549-7
Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects.
N. Jain (2002)
10.1016/j.neuropharm.2005.12.002
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
J. Guindon (2006)
10.1016/J.EJPHAR.2006.07.024
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
V. Haller (2006)
10.1038/sj.bjp.0704113
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen
S. Holt (2001)
10.1016/j.pain.2005.12.007
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain
J. Guindon (2006)
10.5860/choice.34-3310
Guide for the Care and Use of Laboratory Animals
Division on Earth (1996)
10.1124/jpet.108.146316
Mice Selectively Bred for High- or Low-Alcohol-Induced Locomotion Exhibit Differences in Dopamine Neuron Function
M. Beckstead (2009)
The nuclear receptor PPAR-{alpha} mediates the antiinflammatory actions of palmitoylethanolamide
J Lo Verme (2005)
10.1016/0014-2999(76)90004-2
Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents.
R. Vinegar (1976)
alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution.
D. Boger (2001)
10.1124/MOL.104.006353
The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide
J. Lo Verme (2005)
10.1124/jpet.108.145854
The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes
C. S. Endres (2009)
10.1172/JCI19465
The endogenous cannabinoid system protects against colonic inflammation.
F. Massa (2004)
10.1046/J.1432-1327.1999.00631.X
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages.
V. Di Marzo (1999)
10.1038/sj.bjp.0706773
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Leon Chang (2006)
10.1213/01.ane.0000194587.94260.1d
The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and Ketorolac
A. Ulugöl (2006)
10.1016/S0361-9230(03)00144-8
Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs
H. Miranda (2003)
10.1038/NEWBIO231232A0
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
J. Vane (1971)
10.1523/JNEUROSCI.3326-06.2006
Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain
M. Jhaveri (2006)
10.1073/PNAS.0509591102
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
G. Gobbi (2005)
10.1016/j.pain.2004.01.022
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
A. Lichtman (2004)
10.1124/JPET.104.069401
Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity
A. Lichtman (2004)
10.1124/jpet.108.150136
Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus
J. Schlosburg (2009)
N - ( 2hydroxyethyl ) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by downmodulating mast cell activation
HF Miranda (1996)
10.1073/PNAS.0401292101
Functional disassociation of the central and peripheral fatty acid amide signaling systems.
B. Cravatt (2004)
10.1021/BI0608008
A FAAH-regulated class of N-acyl taurines that activates TRP ion channels.
A. Saghatelian (2006)
10.1007/s00109-008-0359-6
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
M. Storr (2008)
Fleckenstein JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide
Salvatore Ndengele
PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between
X Pregnane
10.1124/jpet.108.143214
Myrtucommulone from Myrtus communis Exhibits Potent Anti-Inflammatory Effectiveness in Vivo
A. Rossi (2009)
10.1124/jpet.108.148536
Metabolic Activation of Mifepristone [RU486; 17β-Hydroxy-11β-(4-dimethylaminophenyl)-17α-(1-propynyl)-estra-4,9-dien-3-one] by Mammalian Cytochromes P450 and the Mechanism-Based Inactivation of Human CYP2B6
H. Lin (2009)
This paper is referenced by
10.3390/ph3051335
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
H. Vanegas (2010)
10.1016/j.pbb.2018.12.009
CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation
K. Trexler (2019)
Title Multitarget Fatty acid amide hydrolase / cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage Permalink
O. Sasso (2015)
10.1016/j.ejmech.2015.12.036
Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
Marco Migliore (2016)
10.1016/j.biopsych.2011.04.022
Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses
Arnau Busquets-Garcia (2011)
10.1016/j.ejphar.2017.05.006
MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice
M. Crowe (2017)
10.1038/nrd3673
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
B. Roques (2012)
10.3109/14756366.2011.643304
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
C. Fowler (2013)
10.1016/j.neuropharm.2016.11.015
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
J. Wilkerson (2017)
The endocannabinoid system : a translational study from Achilles tendinosis to cyclooxygenase
Emmelie Björklund (2014)
10.1016/j.ejps.2013.11.012
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.
M. Salaga (2014)
10.1152/ajpgi.00463.2014
Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges.
B. Greenwood-Van Meerveld (2015)
Inhibition of monoacylglycerol lipase ( MAGL ) attenuates NSAID-induced gastric hemorrhages in mice
S. Kinsey (2011)
10.1111/j.1476-5381.2012.01950.x
Monoacylglycerol lipase – a target for drug development?
C. Fowler (2012)
Identification and characterization of carprofen as a multi-target FAAH / COX inhibitor
Angelo D. Favia (2013)
10.1124/jpet.116.236182
Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice
G. Donvito (2016)
10.1021/jm3011146
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
Angelo D. Favia (2012)
10.1017/S0029665113003649
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
R. Pertwee (2014)
10.1016/j.neuropharm.2013.09.022
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats
G. Galdino (2014)
10.1016/j.ejphar.2013.01.077
Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies.
X. Nadal (2013)
10.33915/etd.515
Synergistic inhibition of cyclooxygenases and monoacylglycerol lipase in neuropathic pain
M. Crowe (2019)
10.2174/1570159X14666160303110150
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
K. Gyires (2016)
10.1016/j.lfs.2012.06.020
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.
Sudeshna Ghosh (2013)
10.1007/164_2016_105
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.
U. Taschler (2017)
10.3390/ijms21041423
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
M. Z. Hossain (2020)
10.1096/fj.15-270637
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage
O. Sasso (2015)
10.1093/acprof:oso/9780199662685.003.0015
Non-Phytocannabinoid Constituents of Cannabis and Herbal Synergy
J. Mcpartland (2014)
10.1016/j.pain.2014.05.005
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
Chenchen Feng (2014)
10.1021/ja308733u
A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.
Laura Bertolacci (2013)
10.1016/j.bmcl.2014.10.064
Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.
Tyler M. Rose (2014)
10.1016/j.ejphar.2013.09.065
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Mariateresa Cipriano (2013)
10.1111/bph.12298
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
B. Ignatowska-Jankowska (2014)
See more
Some data provided by SemanticScholar